Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hornyak, M.
Right arrow Articles by Voderholzer, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hornyak, M.
Right arrow Articles by Voderholzer, U.
Related Collections
Right arrow Endocrine
Right arrow All Movement Disorders
Right arrow All Sleep Disorders
Right arrow Restless legs syndrome
NEUROLOGY 2008;70:1620-1622
© 2008 American Academy of Neurology

Low-dose hydrocortisone in the evening modulates symptom severity in restless legs syndrome

M. Hornyak, MD, A. Rupp, D. Riemann, PhD, B. Feige, M. Berger and U. Voderholzer, MD

From the Center for Sleep Research and Sleep Medicine, Department of Psychiatry and Psychotherapy, University Medical Center, Freiburg, Germany.

Address correspondence and reprint requests to Dr. Magdolna Hornyak, Interdisciplinary Pain Center, Breisacher Strasse 64, D-79106 Freiburg, Germany magdolna.hornyak{at}uniklinik-freiburg.de

Background: Circadian symptom manifestation in the evening and night is one of the main characteristics of restless legs syndrome (RLS). Although the inverse temporal course of corticosteroid rhythm and RLS symptom severity is obvious, this relationship has yet to be studied. We investigated the effect of late-evening application of exogenous cortisol (hydrocortisone) on sensory leg discomfort (SLD), one of the main complaints of patients with RLS.

Methods: Ten untreated patients with idiopathic RLS participated in the study. Change of SLD was rated on a visual analogue scale during the 60 minutes resting period of the so-called Suggested Immobilization Test. Patients received either hydrocortisone 40 mg or placebo (saline) IV in random order in a double-blind crossover design, with 1 week between the experiments.

Results: Severity of SLD was lower during hydrocortisone infusion than during placebo (p = 0.032). Though blind to the experimental condition, 5 of the 10 patients experienced improvement in symptoms during hydrocortisone administration, but no patient felt an amelioration during the placebo condition.

Conclusions: Our data indicate a probable physiologic relationship between evening and early night hour restless legs syndrome symptom increase and low cortisol level.

Abbreviations: ANOVA = analysis of variance; HPA = hypothalamic-pituitary-adrenal axis; PLMW = periodic leg movements during the resting wake state; PSG = polysomnography; RLS = restless legs syndrome; SIT = suggested immobilization test; SLD = sensory leg discomfort.

Disclosure: The authors report no conflicts of interest.

Received October 29, 2006. Accepted in final form January 8, 2008.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by AAN Enterprises, Inc.